The Scientific Advisory Board (SAB) of CurePSP, advises the Board of Directors on scientific and medical matters, assists with the educational and research activities of the organization, and reviews research grant applications/proposals on a semi-annual basis.

Voting members of the Scientific Advisory Board are prominent scientists and clinicians with expertise pertinent to PSP and CBD genetics, pathology, pathophysiology, clinical manifestations, and management.

Chair, Lawrence I. Golbe, MD
Professor of Neurology
Robert Wood Johnson School of Medicine
New Brunswick, NJ

Lester I. Binder, PhD
Professor
Feinberg School of Medicine
Northwestern University
Chicago, IL

James Clements, PhD
Roswell Cancer Institute
Buffalo, NY

Ted M. Dawson, MD
The Institute for Cell Engineering
Johns Hopkins University School of Medicine
Baltimore, MD

Dennis W. Dickson, MD
Neuropathology Consultant
Mayo Clinic
Jacksonville, FL

Etienne C. Hirsch, PhD
Experimental Neurology & Therapeutics
French Institute of Health & Medical Research
Paris, France

Günter U. Höglinger, MD
Head of Experimental Neurology Unit
Marburg University, Germany

Virginia M.-Y. Lee, PhD
The John H. Ware, III Professor
in Alzheimer’s Research Center for Neurodegenerative Disease Research
University of Pennsylvania School of Medicine
Philadelphia, PA

Andrew J. Lees, MD FRCP
National Hospital for Neurology & Neurosurgery
United Kingdom

Irene Litvan, MD
Raymond Lee Lebby Professor of Parkinson’s Disease Research
University of Louisville School of Medicine
Louisville, KY

Christiane Richter-Landsberg, PhD
Professor, Molecular Neurobiology
University of Oldenburg
Oldenburg, Germany

David E. Riley, MD
University Hospital of Cleveland
Cleveland, OH

Gerard D. Schellenberg, PhD
Research Professor of Medicine & Neurology
University of Washington School of Medicine
Seattle, WA

Eduardo Tolosa, MD
Professor of Neurology
University of Barcelona Hospital Clinic
Barcelona, Spain

Richard Gordon Zyne, DMin
President, CEO
CurePSP
Ex Officio